— Know what they know.
Not Investment Advice

ESRX NASDAQ

Express Scripts Holding Company
1W: -6.0% 1M: -3.1% 3M: -2.4% 1Y: +24.8% 3Y: +5.9% 5Y: +36.0%
$92.33
Last traded 2018-12-21 — delisted
NASDAQ · Healthcare · Medical - Pharmaceuticals

Balance Sheet Trends

Total Assets
$54.3B +4.9% ▲
5Y CAGR: -1.4%
Total Liabilities
$36.1B +1.8% ▲
5Y CAGR: +0.8%
Shareholders Equity
$18.1B +11.6% ▲
5Y CAGR: -5.0%
Cash & Investments
$2.3B -24.9% ▼
5Y CAGR: -3.7%
Total Debt
$16.0B +2.9% ▲
5Y CAGR: +0.1%
Net Debt
$13.7B +9.7% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2013FY2014FY2015FY2016FY2017
— Assets —
Cash$2.0B$1.8B$3.2B$3.1B$2.3B
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$2.0B$1.8B$3.2B$3.1B$2.3B
Net Receivables$4.0B$6.0B$6.7B$7.1B$7.1B
Inventory$1.9B$2.1B$2.0B$2.0B$2.1B
Other Current Assets$509M$400M$0$0$0
Total Current Assets$8.5B$10.6B$12.1B$12.4B$12.0B
Property, Plant & Equip.$1.7B$1.6B$1.3B$1.3B$1.4B
Goodwill & Intangibles$43.3B$41.5B$39.7B$37.9B$40.7B
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$77M$111M$146M$193M$207M
Total Non-Current Assets$45.1B$43.2B$41.2B$39.4B$42.3B
Total Assets$53.5B$53.8B$53.2B$51.7B$54.3B
— Liabilities —
Accounts Payable$2.9B$3.1B$3.5B$3.9B$3.8B
Short-Term Debt$1.6B$2.6B$1.6B$722M$1.0B
Deferred Revenue$8.8B$0$0$0$0
Other Current Liabilities$1M$0$0$0$0
Total Current Liabilities$13.2B$17.0B$17.2B$16.4B$17.8B
Long-Term Debt$12.4B$11.0B$13.9B$14.8B$15.0B
Other Non-Current Liab.$664M$782M$691M$624M$740M
Total Non-Current Liabilities$18.5B$16.7B$18.7B$19.1B$18.3B
Total Liabilities$31.7B$33.7B$35.9B$35.5B$36.1B
— Equity —
Common Stock$8M$8M$8M$9M$9M
Retained Earnings$3.9B$5.9B$8.4B$11.8B$16.3B
Accumulated OCI$12M$2M-$14M-$12M-$3M
Total Stockholders Equity$21.8B$20.1B$17.4B$16.2B$18.1B
Total Liabilities & Equity$53.5B$53.8B$53.2B$51.7B$54.3B
— Key Metrics —
Total Debt$13.9B$13.6B$15.6B$15.6B$16.0B
Net Debt$12.0B$11.7B$12.4B$12.5B$13.7B
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms